切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2016, Vol. 04 ›› Issue (04) : 205 -212. doi: 10.3877/cma.j.issn.2095-5820.2016.04.004

所属专题: 文献

专家论坛

个性化质量控制计划及其对临床实验室质量管理的影响
黄海霞1, 申子瑜1,()   
  1. 1. 510005 广州金域医学检验中心
  • 收稿日期:2016-10-29 出版日期:2016-11-28
  • 通信作者: 申子瑜

Individualized quality control plan and its impact on quality management of clinical laboratories

Haixia Huang1, Ziyu Shen1,()   

  1. 1. Guangzhou KingMed Center for Clinical Laboratory, Guangzhou 510005, China
  • Received:2016-10-29 Published:2016-11-28
  • Corresponding author: Ziyu Shen
  • About author:
    Corresponding author: Shen Ziyu, Email:
引用本文:

黄海霞, 申子瑜. 个性化质量控制计划及其对临床实验室质量管理的影响[J]. 中华临床实验室管理电子杂志, 2016, 04(04): 205-212.

Haixia Huang, Ziyu Shen. Individualized quality control plan and its impact on quality management of clinical laboratories[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2016, 04(04): 205-212.

个性化质量控制计划(individualized quality control plan,IQCP)是一个基于不同临床实验室风险评估和特定条件而产生的全方位的质量保证方案,由美国联邦医疗保险和医疗补助服务中心(the Centers for Medicare & Medicaid Services,CMS)在42 CFR 493.1256法规条款中颁布,从2016年1月份开始在遵循临床实验室改进法案修正案(Clinical Laboratory Improvement Amendments,CLIA)的临床实验室推行,主要针对非豁免检测项目。

本文通过介绍IQCP的内容、使用范围和制定方法,跟进国际上临床实验室和监管机构对IQCP的理解和执行情况,尝试探讨IQCP对中国临床实验室尝试新的质量管理的意义和启发,为进一步探索如何在符合我国国家法律法规的框架下,引导不同地区不同层级检验机构在实验室管理行为上采取针对性的措施和个性化的解决方案提供思路。

The Clinical Laboratory Improvement Amendments (CLIA) individualized quality control plan (IQCP) is a risk-based, objective approach to performing quality control testing. It is based on assessment of the unique laboratory testing in use, patient populations and other aspects (for example, internal quality checks built into new instruments). IQCP is the implemented under the Centers for Medicare & Medicaid Services (CMS) regulation 42 CFR 493.1256 Standard: Control Procedures, and apply to most CMS-certified current and new non-waived tests. IQCP is an all-inclusive approach to quality based on risk management to address potential errors in the total testing process.

In this article, we introduce the concept of IQCP and discuss the overall situation of IQCP implementation so far. Hopefully, this new idea of quality plan could provide clues on how to improve quality management based on each clinical lab′s specific situation in China.

图1 IQCP由三部分内容组成
图2 CLSI EP-23的风险矩阵图
图3 CAP发布的实验室如何决定采用IQCP的流程图
图4 针对IQCP的准备和实行情况的调查
1
中国合格评定国家认可委员会. CNAS-CL02临床实验室质量和能力认可准则(ISO15189:2012, IDT)[S]. 2013-11-22.
2
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Centers for Medicare & Medicaid Services. Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule[S]. Fed Regist, 2003,68(16):3639-3714.
3
U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services. Medicare program; prospective payment system for federally qualified health centers; changes to contracting policies for rural health clinics; and changes to Clinical Laboratory Improvement Amendments of 1988 enforcement actions for proficiency testing referral. Final rule with comment period[S]. Fed Regist. 2014,79(85):25435-25482.
4
U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Director survey and certification group. individualized quality control Plan (IQCP): a New quality control (QC) option[R]. CMS Survey & Certification Letter 13-54, 2013-08-16.
5
U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services. CLIA Advance copy-revised appendix C-survey procedures and interpretive guidelines for laboratories and laboratory services[EB/OL]. 2015-05-29[2016-10-17].

URL    
6
Laessig RH, Ehrmeyer SS. CLIA 2003′s new concept: equivalent quality control[J]. MLO Med Lab Obs, 2005,37(1):32-34.
7
U.S. Clinical and Laboratory Standards Institute. Laboratory quality control based on risk management: approved guideline, CLSI document EP23-A[S]. Wayne, PA: Clinical and Laboratory Standards Institute. 2011.
8
Guidance for §493.1256(d). The State operations manual, appendix C-survey procedures and interpretive guidelines for laboratories and laboratory services[EB/OL]. [2016-10-17].

URL    
9
Westgard JO. Perspectives on quality control, risk management, and analytical quality management [J]. Clin Lab Med, 2013,33(1):1-14.
10
Sharp SE, Miller MB, Hindler J. Individualized quality control plan (IQCP): is it value-added for clinical microbiology[J]? J Clin Microbiol. 2015,53(12):3719-3722
11
U.S. Centers for Medicare & Medicaid Services. FAQs for IQCP[EB/OL]. 2015 [2016-10-17].

URL    
12
U.S. Centers for Medicare & Medicaid Services. CLIA Brochures 11-13[EB/OL]. [2016-10-17].

URL    
13
U.S. Commission on Office Laboratory Accreditation. IQCP: what you need to know [EB/OL]. [2016-10-17]. Prepublication Standards-New and Revised Standards for Individualized Quality Control.

URL    
14
U.S. Centers for Medicare & Medicaid Services, Centers for Disease Control and Prevention. Developing an IQCP: a step-by-step guide [EB/OL]. [2016-10-17].

URL    
15
U.S. Clinical and Laboratory Standards Institute. EP18/EP23 sources of failure, free electronic template[EB/OL]. [2016-10-17].

URL    
16
Miller G, Quintenz A. IQCP and more: what′s on the horizon for 2015[J]? MLO Med Lab Obs, 2015, 47(1):18, 20.
17
Orton S. Understanding the CLIA individualized quality control plan (IQCP)[J]. MLO Med Lab Obs, 2014, 46(5):36, 38.
18
Skala K. IQCP for blood gas testing[J]. MLO Med Lab Obs, 2014, 46(8):26-27.
19
Anderson N. The individualized quality control plan-coming soon to clinical microbiology laboratories everywhere[J]. Clin Microbiol Newsl. 2015,37(22):177-185.
20
American Society for Microbiology. Clinical microbiology portal: IQCP[EB/OL]. [2016-10-17].

URL    
21
Paxton A. IQCP worries? Help with what ends and begins[EB/OL]. Cap Today, 2015-7[2016-10-17].

URL    
22
The Joint Commission International. Revisions related to IQCP option for clinical laboratories // ACCEPTED: revisions related to IQCP option for clinical laboratories[EB/OL]. 2015,35(8):4-8.

URL    
23
College of American Pathologists. CAP 2015 checklist-proposed CAP checklist requirements[EB/OL]. [2016-10-17].

URL    
24
College of American Pathologists. Notification to CAP-accredited laboratories: individualized quality control plan (IQCP)[EB/OL]. [2016-10-17].

URL    
25
BIO-RAD. IQCP: Ask the experts[EB/OL]. 2015-7-22. [2016-10-17].

URL    
26
Westgard J. The 2015 IQCP survey: are individual labs prepared to plan their quality[EB/OL]? [2016-10-17].

URL    
27
Westgard J. The 2015 IQCP survey: the view from labs outside[EB/OL]. [2016-10-17].

URL    
28
Lee B. What is an IQCP? Where do we go from here[EB/OL]? [2016-10-17].

URL    
29
Anderson M. Quality control based on risk management-A concept whose time has arrived [S]. Clin Leader Manag Rev, 2014.
30
中华人民共和国国家质量监督检验检疫总局, 中国国家标准化管理委员会. GB/T 20468-2006临床实验室定量测定室内质量控制指南[S]. 北京: 中国标准出版社, 2007.
[1] 陈舜, 薛恩生. 福建省超声医学质量控制检查评价分析及对策[J]. 中华医学超声杂志(电子版), 2022, 19(03): 267-271.
[2] 桂阳, 朱庆莉, 韦瑶, 张晓燕, 张青, 吕珂, 李建初, 姜玉新. 优化门诊流程在超声报告质量改进方面的应用[J]. 中华医学超声杂志(电子版), 2022, 19(01): 55-58.
[3] 张晓燕, 王红燕, 王亚红, 杨筱, 张青, 韦瑶, 王莹, 徐雯, 朱庆莉, 李建初. 标准化医疗质量管理PDCA流程在超声科中的应用[J]. 中华医学超声杂志(电子版), 2021, 18(11): 1096-1100.
[4] 董虹美, 张晓航, 王希, 王彦, 张玉, 冉素真. PDSA循环在胎儿大脑中动脉超声检查质量控制中的应用[J]. 中华医学超声杂志(电子版), 2021, 18(07): 657-663.
[5] 赵庆华, 王春霞, 潘小杰, 王静, 史淼, 张东东, 王倩, 王亮亮. 超声科"危急值"制度的落实评估与持续改进策略[J]. 中华医学超声杂志(电子版), 2020, 17(07): 662-666.
[6] 张家怡, 张玉泉. 妇产科患者静脉血栓栓塞症风险评估模型的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(01): 15-22.
[7] 林靖雯, 王佳佳, 王洪萍. 三种龋风险评估方法在0 ~ 3岁儿童中的应用比较[J]. 中华口腔医学研究杂志(电子版), 2023, 17(02): 118-122.
[8] 李腾成, 狄金明. 2023 V1版前列腺癌NCCN指南更新要点解读[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 313-318.
[9] 南方护骨联盟前列腺癌骨转移专家组. 前列腺癌骨转移诊疗专家共识(2023版)[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 201-208.
[10] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[11] 闫林平, 崔怡, 周红艳, 周颖, 周文琦, 张亚辉, 东潇妹. 三种压力性损伤评估量表在老年髋部骨折围手术期患者中的应用研究[J]. 中华老年骨科与康复电子杂志, 2021, 07(04): 231-237.
[12] 甄拴平, 王华, 朱海鹏, 豆淑媛, 赵雪莲. 基层医院检验危急值管理的实践与探讨[J]. 中华临床实验室管理电子杂志, 2023, 11(01): 1-4,15.
[13] 吴志成, 谢闻悦, 沈茂婷, 陈娟. 基于风险管理的Westgard西格玛分析批长度规则在尿液有形成分定量检测方法质量控制中的应用[J]. 中华临床实验室管理电子杂志, 2022, 10(01): 29-33.
[14] 张林叶, 柏战, 王宗方, 潘文君. GRACE 2.0评分对老年急性心肌梗死患者经皮冠状动脉介入治疗后急性肾损伤的预测价值[J]. 中华老年病研究电子杂志, 2022, 09(04): 6-11.
[15] 白艳, 董秋梅, 王雄耀. 颈动脉粥样硬化性缺血性卒中风险评估的研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(06): 439-442.
阅读次数
全文


摘要